NRC AN 019 / NATCO - LARVOL DELTA

[Retracted] Antitumor activity of NRC‑AN‑019 in a pre‑clinical breast cancer model. (PubMed, Int J Oncol) - "6A on p. 647 were unexpectedly similar to the tumor images shown five rows down for the 30 mg/kg Lapatinib administration experiment, albeit the images were turned through 180°...The Editor apologizes to the readership for any inconvenience caused. [International Journal of Oncology 39: 641‑648, 2011; DOI: 10.3892/ijo.2011.1079]."

Journal • Preclinical • Breast Cancer • Oncology • Solid Tumor

[Retracted] Design, synthesis and preclinical evaluation of NRC‑AN‑019. (PubMed, Int J Oncol) - "The Editor apologizes to the readership for any inconvenience caused. [International Journal of Oncology 42: 168‑178, 2013; DOI: 10.3892/ijo.2012.1697]."

Journal • Preclinical • Chronic Myeloid Leukemia • Hematological Malignancies • Leukemia • Oncology